Automatic Deep Learning System for COVID-19 Infection Quantification in chest CT

Omar Ibrahim Alirr
DOI: https://doi.org/10.48550/arXiv.2010.01982
2020-10-02
Abstract:Coronavirus Disease spread globally and infected millions of people quickly, causing high pressure on the health-system facilities. PCR screening is the adopted diagnostic testing method for COVID-19 detection. However, PCR is criticized due its low sensitivity ratios, also, it is time-consuming and manual complicated process. CT imaging proved its ability to detect the disease even for asymptotic patients, which make it a trustworthy alternative for PCR. In addition, the appearance of COVID-19 infections in CT slices, offers high potential to support in disease evolution monitoring using automated infection segmentation methods. However, COVID-19 infection areas include high variations in term of size, shape, contrast and intensity homogeneity, which impose a big challenge on segmentation process. To address these challenges, this paper proposed an automatic deep learning system for COVID-19 infection areas segmentation. The system include different steps to enhance and improve infection areas appearance in the CT slices so they can be learned efficiently using the deep network. The system start prepare the region of interest by segmenting the lung organ, which then undergo edge enhancing diffusion filtering (EED) to improve the infection areas contrast and intensity homogeneity. The proposed FCN is implemented using U-net architecture with modified residual block with concatenation skip connection. The block improves the learning of gradient values by forwarding the infection area features through the network. To demonstrate the generalization and effectiveness of the proposed system, it is trained and tested using many 2D CT slices extracted from diverse datasets from different sources. The proposed system is evaluated using different measures and achieved dice overlapping score of 0.961 and 0.780 for lung and infection areas segmentation, respectively.
Image and Video Processing,Computer Vision and Pattern Recognition
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop an automated deep - learning system for quantifying the COVID - 19 - infected areas in chest CT scans. Specifically, the paper proposes solutions to the following challenges: 1. **Limitations of PCR tests**: Although PCR is the primary method for diagnosing COVID - 19, it has low sensitivity, is time - consuming, and is complex to operate. Therefore, a faster and more accurate auxiliary screening tool is required. 2. **Advantages of CT images**: CT imaging performs well in detecting COVID - 19, especially for asymptomatic patients. CT images can be used as a complementary tool to PCR for disease monitoring and progress assessment. 3. **Challenges in segmenting infected areas**: There is a high degree of variation in the size, shape, contrast, and intensity uniformity of COVID - 19 - infected areas in CT slices, which poses a huge challenge to the segmentation process. To address these challenges, the paper proposes an automated deep - learning system, which mainly includes the following steps: 1. **Lung segmentation**: First, the region of interest (ROI) is determined by segmenting the lungs, so as to enable more accurate segmentation of the infected areas later. 2. **Edge - enhancing diffusion filtering (EED)**: Apply EED filtering to the segmented lung areas to improve the contrast and intensity uniformity of the infected areas. 3. **Deep convolutional network (FCN)**: Use an improved U - Net architecture, combined with residual blocks and skip connections, to construct two cascaded FCN networks for segmenting the lungs and the infected areas respectively. 4. **Data sets and training**: Use multiple publicly available CT data sets for training and testing to ensure the generalization ability and effectiveness of the system. Through these steps, the paper aims to provide an efficient and accurate automated system for segmenting and quantifying COVID - 19 - infected areas, thus supporting clinical diagnosis and treatment.